Walmart on Health: Congress, Take Note By Leah Binder Away from the noise in Washington, there’s a quiet movement among employers to improve healthcare and lower costs, and it’s making progress.
Are Patients Ready to Take Control? By Michael Levin Consumers still don't seem to understand how to manage healthcare and its costs -- but, increasingly, there's an app for that.
Genomic Data: the DNA of Insurance? By Ross Campbell There are potentially significant benefits for consumers who allow access to data on their lifestyle, activity, medical history and genetic makeup.
Healthcare Needs a Data Checkup By Byron Acohido This haste to complete implementation of electronic health records has led to a deficiency in data protection and security measures.
Is This the Largest Undisclosed Risk? By Dave Chase Scrutiny on ERISA-regulated health plans' spending could create immense liability for both company directors and health insurers.
To Predict the Future, Try Creating It By Ross Campbell Life insurers can offer modular products--that can be built up or down and switched on and off to reflect much better how life’s risks ebb and flow.
The True Face of Opioid Addiction By David Hom The tough reality is that addicts are everywhere. We need to start using behavioral analytics to help identify them and help them in time.
A Way to Reduce Healthcare Costs By Dawn Morton-Rias Insurers and all healthcare stakeholders can benefit from broadening use of certified physician assistants.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.